Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Pridopidine

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Prilenia & Ferrer Share Data on Pridopidine in Huntington Disease
    Prilenia & Ferrer Share Data on Pridopidine in Huntington Disease

    10 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251010035801/en/Prilenia-and-Ferrer-to-Share-New-Data-and-Analyses-of-Pridopidines-Impact-on-Huntingtons-Disease-at-the-Huntington-Study-Group-HSG-Congress

    BUSINESSWIRE
    10 Oct 2025
    Share Share
    Pridopidine Phase 3 ALS Study Revealed At NEALS 2025 Conference
    Pridopidine Phase 3 ALS Study Revealed At NEALS 2025 Conference

    06 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251006420172/en/Pridopidine-Pivotal-Phase-3-ALS-Study-Unveiled-at-NEALS-2025-Annual-Meeting

    BUSINESSWIRE
    06 Oct 2025
    Share Share
    Phase 3 Data on Pridopidine in Early Huntington’s Published
    Phase 3 Data on Pridopidine in Early Huntington’s Published

    05 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250905555323/en/Nature-Medicine-Publishes-Phase-3-Data-on-Pridopidine-in-Early-Stage-Huntingtons-Disease-Highlighting-Impact-on-Clinical-Progression

    BUSINESSWIRE
    05 Sep 2025
    Share Share
    Prilenia, Ferrer Give EU Update on Pridopidine in Huntington
    Prilenia, Ferrer Give EU Update on Pridopidine in Huntington

    25 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250725635763/en/Prilenia-and-Ferrer-Provide-Update-on-European-Regulatory-Process-for-Pridopidine-in-Huntingtons-Disease

    BUSINESSWIRE
    25 Jul 2025
    Share Share
    Ferrer collaboration with Prilenia for Pridopidine deal
    Ferrer collaboration with Prilenia for Pridopidine deal

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250427034068/en/Ferrer-Enters-Into-a-Collaboration-and-License-Agreement-With-Prilenia-for-the-Commercialization-and-Co-Development-of-Pridopidine

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    We Enter into Collab & License Deal With Prilenia For Pridopidine
    We Enter into Collab & License Deal With Prilenia For Pridopidine

    28 Apr 2025

    // PRESS RELEASE

    https://www.ferrer.com/en/Ferrer-enters-into-a-collaboration-and-license-agreement-with-Prilenia-for-the-commercialization-and-co-development-of-Pridopidine

    PRESS RELEASE
    28 Apr 2025
    Share Share